These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34361978)

  • 21. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
    Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
    Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipenem Population Pharmacokinetics: Therapeutic Drug Monitoring Data Collected in Critically Ill Patients with or without Extracorporeal Membrane Oxygenation.
    Chen W; Zhang D; Lian W; Wang X; Du W; Zhang Z; Guo D; Zhang X; Zhan Q; Li P
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation.
    Touchard C; Aubry A; Eloy P; Bréchot N; Lebreton G; Franchineau G; Besset S; Hékimian G; Nieszkowska A; Leprince P; Luyt CE; Combes A; Schmidt M
    Crit Care; 2018 Aug; 22(1):199. PubMed ID: 30121083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study.
    Kühn D; Metz C; Seiler F; Wehrfritz H; Roth S; Alqudrah M; Becker A; Bracht H; Wagenpfeil S; Hoffmann M; Bals R; Hübner U; Geisel J; Lepper PM; Becker SL
    Crit Care; 2020 Nov; 24(1):664. PubMed ID: 33239110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
    Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
    Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.
    Shekar K; Roberts JA; Welch S; Buscher H; Rudham S; Burrows F; Ghassabian S; Wallis SC; Levkovich B; Pellegrino V; McGuinness S; Parke R; Gilder E; Barnett AG; Walsham J; Mullany DV; Fung YL; Smith MT; Fraser JF
    BMC Anesthesiol; 2012 Nov; 12():29. PubMed ID: 23190792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study.
    Alihodzic D; Wicha SG; Frey OR; König C; Baehr M; Jarczak D; Kluge S; Langebrake C
    Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Drug Monitoring of Voriconazole in Children from a Tertiary Care Center in China.
    Hu L; Dai TT; Zou L; Li TM; Ding XS; Yin T
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30150475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation.
    Sinnah F; Shekar K; Abdul-Aziz MH; Buscher H; Diab SD; Fisquet S; Fung YL; McDonald CI; Reynolds C; Rudham S; Wallis SC; Welch S; Xie J; Fraser JF; Roberts JA;
    Crit Care Resusc; 2017 Oct; 19(Suppl 1):8-14. PubMed ID: 29084496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population Pharmacokinetics of Amikacin in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation.
    Pressiat C; Kudela A; De Roux Q; Khoudour N; Alessandri C; Haouache H; Vodovar D; Woerther PL; Hutin A; Ghaleh B; Hulin A; Mongardon N
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis.
    Gijsen M; Dreesen E; Annaert P; Nicolai J; Debaveye Y; Wauters J; Spriet I
    Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34208553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation.
    Welsch C; Augustin P; Allyn J; Massias L; Montravers P; Allou N
    Transpl Infect Dis; 2015 Feb; 17(1):103-5. PubMed ID: 25572932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes among Patients Treated with Renal Replacement Therapy during Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Study.
    Dado DN; Ainsworth CR; Thomas SB; Huang B; Piper LC; Sams VG; Batchinsky A; Morrow BD; Basel AP; Walter RJ; Mason PE; Chung KK
    Blood Purif; 2020; 49(3):341-347. PubMed ID: 31865351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of Imipenem in Critically Ill Patients with Life-threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation.
    Jaruratanasirikul S; Vattanavanit V; Samaeng M; Nawakitrangsan M; Sriwiriyajan S
    Clin Drug Investig; 2019 Aug; 39(8):787-798. PubMed ID: 31124013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
    Eyler RF; Heung M; Pleva M; Sowinski KM; Park PK; Napolitano LM; Mueller BA
    Pharmacotherapy; 2012 Dec; 32(12):1061-9. PubMed ID: 23208833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
    Ha MA; Sieg AC
    Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxygenator impact on voriconazole in extracorporeal membrane oxygenation circuits.
    Cies JJ; Moore WS; Giliam N; Low T; Marino D; Deacon J; Enache A; Chopra A
    Perfusion; 2020 Sep; 35(6):529-533. PubMed ID: 32627659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study.
    Fang J; Li R; Chen Y; Qin JJ; Hu M; Huang CL; Cheng L; He Y; Li Y; Zhou Q; Zhou DX; Huang F; Lei F; Yang B; Chen J; Deng HP; Yuan YF; Xia JH; Wan S; Li HL; Wei X
    Curr Med Sci; 2021 Feb; 41(1):1-13. PubMed ID: 33582899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrieval of critically ill adults using extracorporeal membrane oxygenation: the nine-year experience in New South Wales.
    Austin DE; Burns B; Lowe D; Cartwright B; Clarke A; Dennis M; D'Souza M; Nathan R; Bannon PG; Gattas D; Connellan M; Forrest P
    Anaesth Intensive Care; 2018 Nov; 46(6):579-588. PubMed ID: 30447667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis.
    Gatti M; Fornaro G; Pasquini Z; Zanoni A; Bartoletti M; Viale P; Pea F
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.